多参数MRI评估HIFU术后疑似复发前列腺癌:动态对比增强序列是否仍需要
回顾性纳入45例临床和生物学怀疑前列腺癌复发的HIFU术后患者,比较T2w+DWI与T2w+DWI+DCE两种方案检测复发的效能,以穿刺活检为金标准。两位阅片者独立评分,结果显示两方案AUC无显著差异,在Likert评分≥3为阈值时,T2w+DWI+DCE与T2w+DWI的敏感度均较高且无显著差异。
要点
- HIFU术后怀疑前列腺癌复发时,多参数MRI可用于监测检测复发。
- 在T2w+DWI基础上加用DCE序列并未显著提高检测复发的敏感度。
- 不同经验程度的阅片者加用DCE后诊断效能均未显著改善。
核心结论
- 在T2w+DWI基础上加用DCE序列并未显著提高多参数MRI检测HIFU术后前列腺癌复发的准确性和敏感度,且不同经验阅片者均无显著获益。
研究设计与样本
- 回顾性研究,纳入45例临床和生物学怀疑前列腺癌复发的HIFU术后男性,所有患者在多参数MRI后接受前列腺穿刺活检,以活检为金标准;两位阅片者独立在T2w+DWI+DCE和T2w+DWI图像上给出癌症可能性Likert评分。
诊断标准与关键数值
- 以Likert评分≥3为前列腺癌诊断阈值,基于穿刺活检金标准,在腺叶水平评估敏感度。
- T2w+DWI+DCE的敏感度:资深阅片者0.97,初级阅片者0.94;T2w+DWI的敏感度:资深阅片者0.94,初级阅片者0.97。
- T2w+DWI与T2w+DWI+DCE的受试者工作特征曲线下面积对两位阅片者均无显著差异。
临床应用与阅片要点
- 多参数MRI可用于HIFU术后前列腺癌复发的监测检测。
- 在T2w+DWI基础上加用DCE序列并未显著改善复发检测的敏感度,不同经验阅片者结果一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the added value of the dynamic contrast-enhanced sequence (DCE) to combination T2-weighted imaging (T2w) + diffusion-weighted imaging (DWI) in detecting prostate cancer (PCa) recurrence after HIFU (high-intensity focused ultrasound).
METHODS: Forty-five males with clinical and biological suspected PCa recurrence were retrospectively selected. All underwent multi-parametric MRI (mpMRI) before biopsies. Two readers independently assigned a Likert score of cancer likelihood on T2w + DWI + DCE and T2w + DWI images. Prostatic biopsies were taken as the gold standard.
RESULTS: Recurrent PCa was identified at biopsy for 37 patients (82%). Areas under the receiver-operating curve of T2w + DWI and T2w + DWI + DCE imaging were not significantly different for both readers. Using a Likert score ≥ 3 for the PCa diagnosis threshold, sensitivity at the lobe level for the (1) senior and (2) junior reader for T2w +DWI +DCE sensitivity was (1) 0.97 and (2) 0.94 vs. (1) 0.94 and (2) 0.97 for T2w + DWI.
CONCLUSION: Accuracy of mpMRI was not significantly improved by adding DCE to T2w + DWI. Sensitivity was high for T2w + DWI + DCE and T2w + DWI with no significant difference for either the junior or senior reader.
KEY POINTS: • MpMRI has the capability to detect PCa recurrence in post-HIFU monitoring. • The sensitivity of T2w and DWI for detecting PCa recurrence was not improved by DCE. • Readers with different degrees of experience did not improve their performance with DCE.
引用
- Lotte R, Lafourcade A, Mozer P, et al. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed? Eur Radiol. 2018. PMID: 29633004. doi:10.1007/s00330-018-5352-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。